Dicer mediating the expression of miR-143 and miR-155 regulates hexokinase II associated cellular response to hypoxia. Am J Physiol Lung Cell Mol Physiol 307: L829 -L837, 2014. First published August 29, 2014; doi:10.1152/ajplung.00081.2014.-Lung alveolar epithelial cells are exposed to hypoxia under a variety of physiological and pathological conditions. It has been shown recently that miR-143, which can directly target the key glycolytic enzyme hexokinase II (HK2), may be regulated by miR-155. We investigated whether microRNAs contribute to the cellular glycolysis in response to hypoxia. Using the A549 cells, we found that the expression of Dicer is decreased under hypoxia. When Dicer was knocked down with small-interfering RNA (siRNA), pre-miR143 was increased and mature miR-143 was decreased as that in hypoxia, indicating that reduction of Dicer is responsible for the change of miR-143 under hypoxia. Interestingly, both hypoxia and knockdown of Dicer resulted in miR-155 and pre-miR-155 expression increases. We also examined the expression of HK2 and glucose metabolism in the cells. Both HK2 mRNA and protein were increased under hypoxia, which is accompanied by an increase of glucose uptake and production of lactate. The same alterations were found with siRNA Dicer knockdown. Moreover, transfection with anti-miR-143 also led to a HK2 production and an increase of glucose uptake and lactate production, whereas antimiR-155 had opposite effects. The miR-143 and anti-miR-155 transfection resulted in a significant cell apoptosis. The expression of Dicer was decreased with HK2 accumulating in mouse lung tissues under hypoxia identified by immunohistochemistry. The changes of miR-143 and miR-155 were similar to those in A549 cells. Our data demonstrate that Dicer regulation of miRNAs promotes HK2 activation and glycolysis, which might protect the cell from hypoxic damage and enter into an adaptive process.
HYPOXIA AFFECTS VARIOUS PHYSIOLOGICAL and pathophysiological responses in lung cells during development, chronic inflammation, and cancer (7, 36) . It also activates protective mechanisms to reduce cell damage or death induced by limited oxygen supply (2, 9) . The hypoxia-inducible factor (HIF) is an important hypoxia-responsive transcription factor that regulates expressions of multiple genes, such as hexokinase II (HK2), to allow cells to adapt to hypoxia (12, 28) . However, the mechanism and signal pathway of the regulation of glycolysis by chronic hypoxia in adaption metabolism has not been fully described.
miRNAs are a group of small endogenously noncoding RNAs that downregulate specific target mRNAs by complementary sequence pairing to target genes in diverse biological processes, including metabolism and tumorigenesis (15) . miRNAs have been shown to be major regulators at posttranscription stages, especially mRNA stabilization, to alter protein expression and metabolism in cancer and normal cells (31, 41) . Specifically, miR-143 and miR-155 have been shown to affect the regulation of the glycolysis pathway by targeting HK2. Furthermore, miR-155 can suppress the production of miR-143 through targeting C/EBP, which is a transcription activator for miR-143 (14) . However, little is known about the role of miRNA in hypoxia adaption and metabolism.
Dicer is a principal component of microRNA (miRNA) processing machinery that processes precursor microRNAs (pre-microRNAs) into mature microRNAs and cleaves doublestranded RNAs into small-interfering RNAs (siRNAs) (19, 29) . There is evidence that chronic hypoxia inhibits the expression and activity of Dicer leading to global consequences on microRNA biogenesis, which established the relationship between hypoxia and microRNAs (4, 13, 34) . Chronic hypoxia leads to the generalized decrease in expression of mature microRNAs and the accumulation of pre-microRNAs (13) . Although chronic hypoxia is a major risk factor in lung disease, the expression and function of Dicer and associated miRNAs in alveolar epithelial cells is unclear. During hypoxia, hexokinase (HK) is the rate-limiting enzyme in the first step of glucose metabolism and utilization in the lung (28) . The HK2 gene is highly expressed and facilitates high rates of glucose catabolism in rapidly growing tumors (17) . However, the production and function of HK2 is not fully understood in lung hypoxia.
In this study, we hypothesized that Dicer regulation of miRNAs has a major influence on HK2 expression that protects apoptosis from chronic hypoxia. We described here miR-143 and miR-155 act as critical regulators of glycolysis and are modulated by the expression of Dicer during chronic hypoxia in A549 cells. Furthermore, the phenomenon was also identified in a mouse model accordingly.
MATERIALS AND METHODS
Cell culture and hypoxia. A549 cells were purchased from the American Type Culture Collection, and the cells were maintained in RPMI 1640 medium (Invitrogen) supplemented with 10% fetal bovine serum (FBS), 100 U/ml of penicillin, 100 g/ml of streptomycin, and 2 mM glutamine at 37°C and 5% CO 2. Reagents were purchased from Sigma, Fisher Scientific, or GIBCO unless otherwise specified. All treatments were performed on cells at 70 -90% confluence on 100-mm polystyrene cell culture plates. Immediately before experimental exposures, fresh medium was added to each plate. We performed hypoxic treatments by incubating the cells within a sealed anaerobic system (model 1025; ThermoForma) at 37°C, in the presence of 1% O 2 maintained using a high-purity anaerobic gas mixture (5% CO2-10% H2-85% N2) with 20 ml medium/plate.
Transient transfection. For Lipofectin2000 (Invitrogen, Carlsbad, CA)-mediated transfection, cells (10 5 cells/ml) were plated in RPMI 1640 containing 10% FBS at 37°C in the presence of 5% CO2 overnight. The next day, we aspirated the medium and replaced with prewarmed Opti-MEM (GIBCO) containing siDicer (sc-40489; Santa Cruz), siHK2 (sc-35621; Santa Cruz), anti-miR-143, anti-miR-155, or control siRNA Lipofectin mix (miR-155 mimics, anti-miR-155, miR-143 mimics, anti-miR-143, and the respective control RNAs were purchased from Ambion). After 4 h, the transfection mix was exchanged with fresh complete RPMI 1640 media, and the cells were incubated for an additional 24 h at 37°C in the presence of 5% CO 2 overnight.
miRNA real-time PCR. Total RNA was purified from cells by using a miRNeasy minikit (Qiagen) according to the manufacturer's protocol. The RNA concentration was measured with a NanoDrop apparatus (NanoDrop Technology) and normalized, and integrity was determined by agarose gel electrophoresis. Reverse transcription was carried out by using a TaqMan MicroRNA reverse transcription kit (Applied Biosystems) according to the manufacturer's protocol. premiR-143, miR-143, pre-miR-155, and miR-155 were detected in human and mouse separately using TaqMan MicroRNA assays with forward primers specific to pre-miRNAs and miRNAs according to the protocol. Real-time quantification of cDNA was performed on an ABI 7500 system (Applied Biosystems) and normalized to 18S rRNA.
mRNA real-time PCR. We purified total RNA using the TRIzol (Invitrogen) method and reverse transcribed using Superscript II (Invitrogen). Real-time quantification of cDNA was performed on the ABI 7500 system and normalized to ␤-actin. The following primers were used.
Western blot analysis. Cells were harvested for Western blotting 24 h after transfection. Samples were probed with Dicer (sc-25117; Santa Cruz), HK2 [ab104836 (human), ab76959 (mouse); Abcam], HIF-1␣ (ab113642; Abcam), and ␤-actin (sc-47778; Santa Cruz) antibody. The signal was visualized by enhanced chemiluminescence (ECL Plus) and captured by VisionWorksLS Image Acquisition and Analysis software (version 6.7.2; UVP). Densitometry analysis was performed using ImageJ.
MTS. MTS assays were performed using the CellTiter 96 AQueous One Solution Cell Proliferation Assay (Promega) according to the manufacturer's instructions. First, the cell viability assays were per- formed as described by the manufacturers by adding 30 l of MTS solution to the 150 l of culture medium in each well. After 90 min of incubation at 37°C, the absorbance was read. For the MTS assay, the maximum endpoint absorbance was read at 490 nm on a microplate reader (SUNRISE; TECAN). In this assay, the inhibition ratio of cell viability was proportional to the ratio of difference OD value between untreated A549 cells and challenged A549 cells to the untreated one. The assay was repeated three times.
Glucose consumption, glycolysis, and ATP contents. A549 cells were seeded in culture dishes, and the medium was changed after 6 h. We incubated cells an additional 24 h and then collected culture medium for measurement of glucose and lactate concentrations at different times during hypoxia. Glucose levels were measured using a Glucose Assay Kit (Sigma). We determined glucose consumption from the difference in glucose concentration compared with control. Lactate levels were determined using an F-kit L-lactate (J. K. International). To measure intracellular ATP levels, a CellTiter-Glo Luminescent Cell Viability assay (Promega) based on ATP requiring luciferin-oxyluciferin conversion mediated by a thermostable luciferase generating a stable "glow-type" luminescent signal was used. The cells were lysed in 100 l of CellTiter-Glo reagent according to the manufacturer's instructions, and the luminescent signal was recorded for 1 s on a high-sensitivity luminometer (Biotek).
Immunofluorescence and confocal microscopy. Cells were washed with PBS after 48 h of transfection and then fixed with 4% paraformaldehyde and permeabilized with 0.5% Triton X-100 in PBS. We used rabbit anti-HK2 (Cell Signaling) as primary antibody and CY5 goat anti-rabbit IgG (Invitrogen) as secondary antibody to visualize HK2 and stained nuclei with DAPI. Cells were imaged with an Olympus FV1000 confocal microscope.
Apoptosis. We detected apoptotic cells using PI staining of treated cells followed by flow cytometry to detect the sub-G 1 peak (23). We cultured A549 cells overnight, and they were treated with miRNAs for 24 h as described in Transient transfection. We harvested floating and adherent cells and incubated at 4°C overnight in the dark with 750 l of a hypotonic buffer (50 g/ml PI in 0.1% sodium citrate plus 0.1% Triton X-100) before flow cytometric analysis using a FACScan flow cytometer (Becton-Dickinson). We acquired data from about 10,000 cells for each condition with FACS.
Animals and hypoxia treatment. BALb/c mice were obtained from the Animal Center of Shanghai Navy Medical Institute. Mice between 8 and 12 wk of age were subjected to either atmospheric O 2 or 8% O2 for 24 h after which they were killed and organs were harvested (13) .
Immunohistochemistry. Paraffin-embedded lung specimens of mice were obtained from the hypoxia model described above. Paraffin-embedded tissues were sliced to 4 m, deparaffinized with xylene, and rehydrated for 3,3=-diaminobenzidine peroxidase immunohistochemistry (IHC) staining using a MaxVisionTMHRPPolymer anti-mouse/rabbit IHC kit (Fuzhou Maxim). Deparaffinized sections were treated with methanol containing 3% hydrogen peroxide for 12 min. After washing with PBS, blocking serum was applied for 30 min. Sections were incubated with Dicer (sc-25117; Santa Cruz) or HK2 (ab76959; Abcam) antibody separately overnight at 4°C. A biotin-marked secondary antibody was applied for 20 min at 37°C, followed by a peroxidase-marked streptavidin for an additional 20 min. After washing, substrate chromogen was used to visualize target proteins. Nuclei were counterstained with hematoxylin. Positive and negative IHC controls were routinely used. Slides were examined using an image analyzer system (Olympus BH-2 microscope; Japan).
Statistical analysis. We present all data as means Ϯ SE of the indicated n independent experiments. We assessed statistical significance using the unpaired two-tailed Student's t-test. The significance is indicated in Figs. 1-8 (P Ͻ 0.05).
RESULTS

Chronic hypoxia affects miR-143 and Dicer expression in A549 cells.
Concentrations of alveolar oxygen are an important factor in many lung diseases. Furthermore, alveolar hypoxia causes an inflammatory response and damages lung cells (3, 9, 16, 21, 35) . TaqMan MicroRNA assays were performed in A549 cells to evaluate the level of precursor and mature miR-143 during lung alveolar epithelial cells under hypoxia. The results show pre-miR-143 increases beginning at 8 h and persisting to 24 h under hypoxic conditions (Fig. 1A) . Interestingly, whereas pre-miR-143 increased more than ninefold compared with normoxic conditions from the beginning of the experiment to 24 h, mature miR-143 decreased by the same magnitude over the same time (Fig. 1, A and B) . Dicer has been recognized as a main component during miRNA maturation. Dicer transcription and protein expression were quantified in A549 cells during chronic hypoxia by qRT-PCR and Western Blot, respectively. As shown in Fig. 1 , C and D, Dicer mRNA and protein were downregulated in a time-dependent manner under hypoxia treatment from 0 to 24 h.
The interference of Dicer inhibits the expression of mature miR-143. According to the above results, we proposed that the level of precursor and mature miR-143 might be influenced by Dicer expression. To identify the relationship between miR-143 and Dicer expression, Dicer siRNA was transfected into A549 cells to interfere with Dicer expression (Fig. 2, A and B) . We found that the expression of pre-miR143 increased, whereas mature miR-143 decreased (Fig. 2, C and D) . This suggests that reduction of Dicer is responsible for the miR-143 modulation under chronic hypoxia.
Hypoxia and knockdown of Dicer result in increases of miR-155 and pre-miR-155. Recently, it was reported that miR-155 can suppress the production of miR-143 through targeting C/EBP, which is a transcription activator for miR-143 (14) . Because we found that Dicer expression decreased under chronic hypoxia and regulated the miR-143 expression, we asked if Dicer and chronic hypoxia could affect miR-155 expression. qRT-PCR analysis revealed that pre-miR-155 and mature miR-155 increased in A549 cells after 8 h under chronic hypoxia (Fig. 3, A and B) and 24 h after Dicer siRNA transfection (Fig. 3, C and D) . The results indicate that miR-155 is regulated by Dicer during chronic hypoxia.
Hypoxia and knockdown of Dicer promote the transcription and expression of HK2 and enhance glycolysis. Hypoxia has been previously shown to regulate transcription and expression of HK2. Recent studies also found that miR-143 and miR-155 affect HK2 regulation in cancers, which can be partly explained by the Warburg effect (14) . Here we demonstrate that Dicer siRNA regulates the expression of miR-143 and miR-155. Subsequently, HK2 expression and glycolysis were monitored to reveal the relationship between Dicer and HK2 in hypoxia. First, the transcription and expression levels of HK2 were determined after 24 h under hypoxia. As expected, the results showed that the expression of HK2 significantly increased after 8 h and persisted to 24 h under hypoxia treatment (Fig. 4, A and B) . Next, it was confirmed that the rates of glucose consumption and lactate production were significantly increased, whereas ATP content decreased in A549 cells under hypoxia for 8 -12 h, consistent with the above results of HK2 expression (Fig. 4, C 
-E). HIF-1␣ is regulated by Dicer in A549 cells under hypoxia. The HIF family responds in a rapid manner to profound reductions in cellular oxygen concentration and constitutes key modulators of hypoxia-responsive genes (33, 42). To identify if
Dicer mediates the expression of HIF-1␣ in A549 cells under chronic hypoxia, Dicer knockdown was performed to observe the changes of HIF-1␣ expression. The results showed that both Dicer interference and hypoxia decreased the Dicer mRNA level in 24 h (Fig. 5A) . Furthermore, HIF-1␣ mRNA was upregulated by Dicer interference and hypoxia within the similar magnitude (Fig. 5B) . Western blot assay also provided evidence that the variation of Dicer promoted HIF-1␣ protein expression during Dicer interference or hypoxia treatment (Fig.  5C ). This suggested that Dicer mediates mature microRNA and HIF-1␣ expression, which plays an important role in posttranscription modulation and alteration of the expression of lots of genes during hypoxia.
Dicer knockdown promotes the expression of HK2 and glycolysis in A549 cells. To explore the effects of Dicer in glycolysis, Dicer interference assay were carried out to observe associated changes on HK2 and glycolysis metabolism. The results showed that Dicer siRNA promoted the expression of HK2 (Fig. 5, D and E) and the activation of the glycolysis system in A549 cells (Fig. 5, F-H) after siDicer transfection for 24 h. Collectively, these results support the theory that Dicer participates in the regulation of HK2 expression and glycolysis up to 24 h under hypoxia treatment.
miR-143 inhibits HK2 expression and glycolysis, whereas miR-155 has opposite effects in A549 cells. It has been shown that downregulation of miR-143, which can directly target the key glycolytic enzyme HK2, promotes glycolysis in tumor cells (6, 14, 40) . To analyze the mechanisms of miRNAs regulating HK2 expression under chronic hypoxia, anti-miR-143 and anti-miR-155 were transfected into A549 cells to identify the function of specific miRNAs on the regulation of HK2 and glycolysis systems separately. HK2 mRNA level in A549 cells treated by anti-miR-143 transfection increased significantly after 24 h (Fig. 6A) . The glucose consumption and lactate production were also enhanced in response to miR-143 inhibition (Fig. 6, B and C) . Respectively, ATP content was decreased during anti-miR-143 transfection (Fig. 6D) . On the contrary, anti-miR-155 transfection decreased the HK2 mRNA level and glycolysis in A549 cells (Fig. 6, E-H) . In addition, the ATP content was maintained in the similar level with or without anti-miR-155 transfection. Confocal results were also consistent with the above results. HK2 expression in cytoplasm of A549 cells was increased with anti-miR-143 and interference of Dicer and attenuated in anti-miR-155-transfected A549 cells (Fig. 7A) .
Apoptosis of A549 cells transfected with miR-143 and antimiR-155 under hypoxia is upregulated.
The reprogramming of energy metabolism is important in the survival and proliferation of many cancers. However, hypoxia modulates specific cell signal pathways, which results in different effects on cancer and normal cells in diverse tissues (6, 14) . Cell proliferation was measured with MTS assay to further describe the potential mechanism and function in hypoxia-regulated glycolysis mediated by Dicer and HK2. The results indicated that the growth of A549 cells was inhibited largely by the treatment of chronic hypoxia, miR-143, and anti-miR-155 (Fig. 7B) . miR-143 and anti-miR-155 in combination with chronic hypoxia decreased the proliferation of A549 cells. Moreover, miR-143 and anti-miR-155 had a strong influence on the inhibition of cell growth under hypoxia. Subsequently, we performed flow cytometry to evaluate apoptosis in A549 cells under the treatments described above. As shown in Fig. 7C , chronic hypoxia induced apoptosis in about 22.5% of A549 cells 24 h after treatment compared with apoptosis in untreated A549 cells. The transfection of miR-143 and anti-miR-155 separately promoted the apoptosis of A549 cells, which was similar to chronic hypoxia. Here we used 1% O 2 as chronic hypoxia conditions, which may decrease the cell apoptosis rate in our research. As we treated cells in the same methods, the cell apoptosis might not be induced by other factors except the transfection or hypoxia compared with the control group. Moreover, in our miRNA transfection assays, we used the most effective dose to induce cell apoptosis to acquire more convincible results, which effect may be much stronger than the effect induced by chronic hypoxia.
Dicer expression is inhibited and HK2 is increased in mouse lung tissues during hypoxia. To identify the expression of Dicer and HK2 in lung tissues under hypoxia, we established the mouse model and measured their expression in lung tissues. qRT-PCR and Western blot showed that Dicer was decreased during hypoxia for 24 h, whereas HK2 was upregulated (Fig. 8,  A-C) . Consistent with the above results about A549 cells, pre-miR-143 was increased and mature miR-143 was impaired in lung tissues under hypoxia (Fig. 8D) . pre-miR-155 and mature miR-155 were also raised in lung tissues under hypoxia (Fig. 8E) . IHC was carried out to exhibit the protein expression of Dicer and HK2. The results showed that Dicer was expressed in cytoplasm of lung tissues within the normoxia condition and impaired during hypoxia for 24 h in mouse lung tissues (Fig. 8F) . HK2 also presented in cytoplasm in mouse lung tissues under normal oxygen and accumulated under the hypoxia condition in 24 h (Fig. 8F) . 
DISCUSSION
In the current study, we found that the precursor of miR-143 is increased, whereas mature miR-143 and transcription and protein expression levels of Dicer are decreased, under chronic hypoxia. Furthermore, when we knocked down Dicer with siRNA, pre-miR143 was increased and miR-143 was decreased, indicating that reduction of Dicer is responsible for the change of miR-143 under hypoxic conditions. Interestingly, both hypoxia and knockdown of Dicer resulted in increases of miR-155 and pre-miR-155, suggesting that residual Dicer may preferentially process pre-miR-155 or the degradation of miR-155 would be delayed under hypoxia. The associated mechanisms need more work to reveal. These results provide evidence to describe the function of Dicer regulating miRNAs during chronic hypoxia in lung alveolar epithelial cells, which gives new understanding of the mechanisms by which miRNAs and associated molecules mediate physiology and pathology progressions in hypoxia.
Although it has been identified that miR-143 is an essential regulator of cancer glycolysis via targeting HK2 in lung and breast cancer (6, 14) , the function of miR-143 on glycolysis during chronic hypoxia has not been fully understood. In this study, we found that hypoxia and interference of Dicer can increase the expression levels of pre-miR-143 but decreases mature miR-143 in A549 cells. These results provide new evidence that Dicer participates in the regulation of miR-143 expression, which have potential function in HK2 production during chronic hypoxia.
miR-155 is a major regulator of numerous biological processes, especially in immune modulation and cancer development. Interestingly, miR-155 is overexpressed in lung cancers, which is associated with poor prognosis in lung cancer patients (5, 37, 39) . In this study, we provide evidence to describe the early stage of chronic hypoxia to explore the roles of miR-155 in glycolysis. We noticed higher levels of miR-155 in A549 cells and lung tissues of mouse models under chronic hypoxia, which is similar to a recent study that used 0.01% oxygen for hypoxic conditions (1) . It suggested that regulation of miR-155 exists in not only tumor cells but also normal lung tissue cells depending on the oxygen concentration. Lung alveolar epithelial cells may be exposed to chronic hypoxia with low oxygen in many disease conditions, such as acute respiratory distress syndrome, chronic inflammation, tumor, etc. (9, 10, 21, 30, 32) . However, oxygen concentration would be different among lung disease, tumor, or anaerobic conditions. Therefore, we studied the function and changes of miR-155 in A549 cells under a chronic hypoxic condition. Our results show that miR-155 expression increases within the impairing of Dicer, which may result in HK2 upregulation and glycolysis. It may indicate that the similar pathway is primed to induce glycolysis both in tumor and normal lung tissues during chronic hypoxia.
We also found that miR-143 expression decreases with Dicer impairment, which may in turn increase HK2 expression and glycolysis. This suggests that Dicer regulates miR-143 and miR-155 levels, which can affect the glycolysis pathway by HK2 within chronic hypoxia.
Hypoxia-induced glycolysis is an important effect in cell adaption under physiological and pathological conditions. HK2 is expressed in lung, spleen, ovary, and testis (11) and selectively regulates lung cells depending on hypoxia (28) . Recent studies provide evidence for the mechanisms of miRNAs regulating HK2 expression and subsequent effects on cancer cells (14, 27, 40) . HIF-1 is tightly regulated by oxygen availability and alters the expression of genes during hypoxia (8, 20) . However, a recent report showed that the expression of HIF-1␣ is regulated by microRNA, which is cleaved by Dicer during hypoxia in several cell lines, such as HUVECs (13) . Here, we also found that Dicer knockdown induces the expression of HIF-1␣. Thus the evidence shows that Dicer is the key molecule regulating the function and metabolism of cells to adapt the chronic hypoxia conditions. In this study, we focused on the effects of Dicer-mediated miR-143 and miR-155 changes on HK2 expression and glycolysis.
Our results showed that the A549 cells, transfected with miR-143 and anti-miR-155 together or separately, exhibit the characters of apoptosis and growth inhibition, which are similar to the appearance to chronic hypoxia. According to the above research, we hypothesize it might be associated with the inhibition of HK2 expression. HK2 is strategically bound to the outer mitochondrial membrane (24, 25) . There, it helps couple ATP formation to the phosphorylation of glucose in mitochondria (22, 26) . This may result in cancer cells with a highly glycolytic phenotype and ample biosynthetic precursors (18, 25, 38) . In addition to its critical metabolic role, HK2 can also promote cancer by inhibiting mitochondrial damage and cell death, and promoting immortalized cancer cells (18) . These findings suggest that Dicer may regulate the expression of miR-143 and miR-155 to promote HK2 to carry out protective effects in lung alveolar epithelial cells during chronic hypoxia.
In this study, we used A549 cells to perform the experiments to explore the Dicer-mediating HK2 expression and the glucose metabolism during chronic hypoxia. A549 cells are lung adenocarcinoma-derived squamous epithelial cells maintained in vitro and have been widely used in lung disease research, including physiology, inflammation, and tumor. A previous report found that HK2 is expressed little in A549 cells and upregulated during hypoxia. However, primary small-airway epithelial cells express more HK2 in normal conditions compared with A549 cells. In addition hypoxia increased the steady-state levels of HK2 mRNA in both cells. Thus we study the HK2 expression and associated glucose metabolism in A549 cells to acquire an obvious effect of HK2 in this study. On the other side, we also confirmed the changes of HK2 expression as well as miR-143 and miR-155 in normal lung tissue of mouse under chronic hypoxia.
In summary, our study provides direct evidence that chronic hypoxia promotes cell glucose metabolism through Dicer regulation of miR-143 and miR-155. HK2 expression may be a potential protective factor in hypoxia-induced damage to avoid cell apoptosis. The results reported here provide an improved understanding of the regulatory network of hypoxia adaption and metabolism and also provide potential targets for the development of miRNA strategies for lung disease therapies.
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